Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Intraepithelial Neoplasia (CIN 2/3)”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Early research (Phase 1)Study completedNCT00685412
What this trial is testing

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Who this might be right for
Papillomavirus Infections
Inovio Pharmaceuticals 18
Early research (Phase 1)Ended earlyNCT00278434
What this trial is testing

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

Who this might be right for
Cervical CancerPrecancerous Condition
University of California, San Francisco 12
Early research (Phase 1)Study completedNCT00988559
What this trial is testing

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Who this might be right for
HPV16 PositiveCervical Intraepithelial Neoplasia (CIN 2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 132
Testing effectiveness (Phase 2)Study completedNCT01022346
What this trial is testing

RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection

Who this might be right for
Cervical Intraepithelial Neoplasia
Hoffmann-La Roche 206
Testing effectiveness (Phase 2)Study completedNCT00121173
What this trial is testing

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Not applicableUnknownNCT02411019
What this trial is testing

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 67
Not applicableStudy completedNCT00601601
What this trial is testing

Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix

Who this might be right for
Cervical CancerPrecancerous Condition
British Columbia Cancer Agency 80
Testing effectiveness (Phase 2)WithdrawnNCT01925378
What this trial is testing

A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Dysplasia
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Study completedNCT00081263
What this trial is testing

Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical CarcinomaCervical Intraepithelial Neoplasia Grade 2/3Stage 0 Cervical Cancer
Gynecologic Oncology Group 130
Not applicableWithdrawnNCT00610662
What this trial is testing

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear

Who this might be right for
Cervical CancerPrecancerous Condition
British Columbia Cancer Agency
Not applicableEnrolling By InvitationNCT04755517
What this trial is testing

Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400)

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2/3Adenocarcinoma in Situ
Tampere University Hospital 14,000
Testing effectiveness (Phase 2)Study completedNCT02864147
What this trial is testing

Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical Dysplasia
Yale University 134
Early research (Phase 1)Ended earlyNCT00005808
What this trial is testing

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical CancerCervical Intraepithelial Neoplasia Grade 2Cervical Intraepithelial Neoplasia Grade 3
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Looking for participantsNCT04098744
What this trial is testing

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Who this might be right for
CIN 2/3HPV InfectionPre-Cancerous Dysplasia+2 more
Frantz Viral Therapeutics, LLC 78
Large-scale testing (Phase 3)Study completedNCT03721978
What this trial is testing

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Who this might be right for
Cervical DysplasiaCervical High Grade Squamous Intraepithelial LesionHSIL
Inovio Pharmaceuticals 203
Not applicableStudy completedNCT01550783
What this trial is testing

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

Who this might be right for
Atypical Squamous Cell of Undetermined SignificanceCervical CarcinomaCervical Intraepithelial Neoplasia Grade 2/3+4 more
University of Washington 1,335
Not applicableStudy completedNCT02811367
What this trial is testing

The HPV Self-test as a Test of Cure in Madagascar

Who this might be right for
Human Papilloma Virus InfectionCervical Intraepithelial Neoplasia Grade 2/3
University Hospital, Geneva 117
Not applicableStudy completedNCT03429582
What this trial is testing

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

Who this might be right for
Cervical Intraepithelial Neoplasia
The Cleveland Clinic 1,154
Not applicableActive Not RecruitingNCT02149030
What this trial is testing

Effectiveness of Cervical Screening in HPV Vaccinated Women

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2/3
Tampere University 6,958
Large-scale testing (Phase 3)UnknownNCT05668572
What this trial is testing

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 12,000
Next Page